HIV 1 News and Research

RSS
Carbon-based antimicrobial nanoweapons to fight COVID-19

Carbon-based antimicrobial nanoweapons to fight COVID-19

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

How can nanomaterials help in the fight against COVID-19?

How can nanomaterials help in the fight against COVID-19?

Nanopore sequencing contradicts human genome integration of SARS-CoV-2

Nanopore sequencing contradicts human genome integration of SARS-CoV-2

New DNA COVID-19 vaccine proven effective in mice

New DNA COVID-19 vaccine proven effective in mice

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

Astodrimer sodium exhibits potent virucidal and antiviral activity against SARS-CoV-2 in vitro

Milder COVID-19 in children may be due to higher memory B cells responses to SARS-CoV-2

Milder COVID-19 in children may be due to higher memory B cells responses to SARS-CoV-2

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

SARS-CoV-2 spike mutations during transmission among humans and to animals

SARS-CoV-2 spike mutations during transmission among humans and to animals

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Celastrol shows potential anti-SARS-CoV-2 activity

Celastrol shows potential anti-SARS-CoV-2 activity

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

Novel PF74 molecule effectively targets HIV capsid protein

Novel PF74 molecule effectively targets HIV capsid protein

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

Arginine methylation important in SARS-CoV-2 viral replication

Arginine methylation important in SARS-CoV-2 viral replication

Developing a COVID-19 vaccine using inactivated E. coli

Developing a COVID-19 vaccine using inactivated E. coli

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.